The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...
Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was ...
Oct 26 (Reuters) - Merck's experimental targeted drug helped women with advanced endometrial cancer live longer and kept ...
Johnson & Johnson (J&J) said that an early-stage trial of JNJ-6143 (previously HLD-0915) found that the novel oral Regulated ...
By Dennis Thompson HealthDay ReporterMONDAY, Oct. 26, 2026 (HealthDay News) — Starting survivorship care for patients with ...
A groundbreaking phase 3 clinical trial reveals that a personalized mRNA vaccine from Merck and Moderna significantly cuts ...
New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer
A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...
In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab ...
Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly ...
ASTRO’s first bladder cancer guideline recommends trimodal therapy as a curative option for selected patients and defines ...
A Journal of Translational Medicine review outlines how mRNA-encoded antibodies, bispecific constructs, and transient CAR ...
Adults and children facing cancer will have access to more advanced treatment options close to home as the AdventHealth Cancer Institute introduces proton therapy. The MEVION S250-FIT™ Proton Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results